{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:39:35Z","timestamp":1771234775986,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1016\/s0049-0172(00)80017-7","type":"journal-article","created":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T13:25:22Z","timestamp":1103721922000},"page":"305-320","source":"Crossref","is-referenced-by-count":155,"title":["The costs of rheumatoid arthritis: an international long-term view"],"prefix":"10.1016","volume":"29","author":[{"given":"Klaus M.","family":"Pugner","sequence":"first","affiliation":[]},{"given":"David I.","family":"Scott","sequence":"additional","affiliation":[]},{"given":"Jeremy W.","family":"Holmes","sequence":"additional","affiliation":[]},{"given":"Klaus","family":"Hieke","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0049-0172(00)80017-7_bib1","first-page":"505","article-title":"Relative importance of musculoskeletal disorders as a cause of chronic health problems, disability, and health care utilization: findings from the 1990 Ontario health survey","volume":"21","author":"Badley","year":"1994","journal-title":"Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib2","first-page":"204","article-title":"The economic burden of musculoskeletal disorders in Canada is similar to that for cancer, and may be higher","volume":"22","author":"Badley","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/art.1780200218","article-title":"The university rheumatic disease clinic: provider and patient perceptions of costs","volume":"20","author":"Henke","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/art.1780260712","article-title":"Social and economic impacts of four musculoskeletal conditions: a study using national community-based data","volume":"26","author":"Kramer","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF00433381","article-title":"The economic impact of musculoskeletal disorders","volume":"3","author":"Lee","year":"1994","journal-title":"Quality of Life Research"},{"key":"10.1016\/S0049-0172(00)80017-7_bib6","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/art.1780381002","article-title":"The economic cost and social psychological impact of musculoskeletal conditions","volume":"38","author":"Yelin","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib7","article-title":"Die volkswirtschaftlichen Kosten von Rheuma in der Bundesrepublik Deutschland","author":"Naujoks","year":"1990","journal-title":"Deutsche Rheuma Liga, Merkblatt Nr. 6.7"},{"key":"10.1016\/S0049-0172(00)80017-7_bib8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/rheumatology\/35.8.781","article-title":"The cost of rheumatoid arthritis","volume":"35","author":"McIntosh","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/art.1780210714","article-title":"The costs of rheumatoid arthritis: a patient-oriented study of chronic disease costs","volume":"21","author":"Meenan","year":"1978","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/art.1780290405","article-title":"A multicenter study of annual health service utilization and costs in rheumatoid arthritis","volume":"29","author":"Lubeck","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/03009749109096811","article-title":"Functional improvement and costs of hip and knee arthroplasty in destructive rheumatoid arthritis","volume":"20","author":"J\u00f6sson","year":"1991","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib12","first-page":"23","article-title":"Stima del costo assistenziale per alcune malattie reumztiche in Italia","volume":"45","author":"Ciocci","year":"1993","journal-title":"Reumatismo"},{"key":"10.1016\/S0049-0172(00)80017-7_bib13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/rheumatology\/35.8.791","article-title":"Treatment of rheumatoid arthritis: does it affect society's cost for the disease?","volume":"35","author":"Magnusson","year":"1996","journal-title":"Br Journal Rheumatol"},{"issue":"Suppl 44","key":"10.1016\/S0049-0172(00)80017-7_bib14","first-page":"47","article-title":"The costs of rheumatoid arthritis: absolute, incremental, and marginal estimates","volume":"23","author":"Yelin","year":"1996","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/S0049-0172(00)80017-7_bib15","first-page":"1051","article-title":"Direct and indirect medical costs incurred by Canadian patients with RA: a 12 year study","volume":"24","author":"Clarke","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib16","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/art.1780400816","article-title":"Resource utilisation and cost of care for RA and OA in a managed care setting","volume":"40","author":"Lanes","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/rheumatology\/37.8.837","article-title":"Direct cost of rheumatoid arthritis during the first six years: a cost-of-illness study","volume":"37","author":"Van Jaarsveld","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib18","series-title":"1st National Congress of Liga Reumatol\u00f3gica Espa\u00f1ola","article-title":"Datos socioecon\u00f3micos de las enfermedades reumatol\u00f3gicas","author":"Tevar","year":"1997"},{"key":"10.1016\/S0049-0172(00)80017-7_bib19","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"1987"},{"key":"10.1016\/S0049-0172(00)80017-7_bib20","series-title":"Epidemiology of the rheumatic disease","author":"Silman","year":"1993"},{"key":"10.1016\/S0049-0172(00)80017-7_bib21","first-page":"462","article-title":"Cross-sectional epidemiological survey of rheumatoid arthritis patients seen in private practice in France: descriptive results (1629 cases)","volume":"65","author":"Sany","year":"1998","journal-title":"Rev Rheum Engl Ed"},{"key":"10.1016\/S0049-0172(00)80017-7_bib22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/03009749609069988","article-title":"In- and out-patient rehabilitation in rheumatoid arthritis: a controlled, open, longitudinal, cost-effectiveness study","volume":"25","author":"Nordstrom","year":"1996","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib23","first-page":"587","article-title":"Changing trends in the hospitalization of patients with rheumatoid arthritis and the future of the inpatient rheumatic disease unit","volume":"21","author":"Blocka","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib24","first-page":"819","article-title":"The lifetime economic costs of rheumatoid arthritis","volume":"11","author":"Stone","year":"1984","journal-title":"J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib25","first-page":"35","article-title":"The cost effectiveness of auranofin: results of a randomized clinical trial","volume":"15","author":"Thompson","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0895-4356(88)90124-2","article-title":"The total cost of care and the use of pharmaceuticals in the management of rheumatoid arthritis: the Medi-Cal program","volume":"41","author":"Jacobs","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib27","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/rheumatology\/37.10.1102","article-title":"Cost-effectiveness and cost-utility of combination therapy in early-rheumatoid arthritis: randomised comparison of combined step-down prednisolone,methotrexate and sulphasalazine with sulphasalazine alone","volume":"37","author":"Verhoeven","year":"1998","journal-title":"Br J Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib28","first-page":"205","article-title":"Benefits of hospitalisation in rheumatoid arthritis","volume":"43","author":"Lee","year":"1974","journal-title":"Q J Med"},{"key":"10.1016\/S0049-0172(00)80017-7_bib29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.1780290507","article-title":"Rehabilitation for rheumatoid arthritis patients: a controlled trial","volume":"29","author":"Spiegel","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib30","first-page":"556","article-title":"Patient outcome following inpatient vs outpatient treatment of rheumatoid arthritis","volume":"15","author":"Anderson","year":"1923","journal-title":"J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib31","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/art.1780361002","article-title":"Inpatient rheumatic disease units: are they worth it?","volume":"36","author":"Clarke","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/bmj.316.7136.965","article-title":"Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation","volume":"316","author":"Lambert","year":"1998","journal-title":"Br Med J"},{"key":"10.1016\/S0049-0172(00)80017-7_bib33","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0049-0172(97)80044-3","article-title":"Socioeconomic evaluation of rheumatoid arthritis and ostcoarthritis: a literature review","volume":"26","author":"Rothfuss","year":"1997","journal-title":"Semin Arthritis Rhea"},{"key":"10.1016\/S0049-0172(00)80017-7_bib34","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/rheumatology\/34.10.966","article-title":"Are slow-acting anti-rheumatic drugs monitored too often? An audit of current clinical practice","volume":"34","author":"Comer","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/art.1780380305","article-title":"The Total costs of drug therapy for rheumatoid arthritis: a model based on costs of drug, monitoring, and toxicity","volume":"38","author":"Prashker","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"suppl 9","key":"10.1016\/S0049-0172(00)80017-7_bib36","first-page":"S195","article-title":"Methotrexate vs parenteral gold: therapeutic use","volume":"37","author":"Kavanaugh","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/03009749009102115","article-title":"Disease-modifying anti-rheumatic drug therapy: an expensive therapy despite inexpensive drugs","volume":"19","author":"Borg","year":"1990","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2036.1998.00287.x","article-title":"Clinical economics review: gastrointestinal complications, of non-steroidal anti-inflammatory drugs","volume":"12","author":"Haslock","year":"1998","journal-title":"Alimentary Pharmacol Ther"},{"key":"10.1016\/S0049-0172(00)80017-7_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/art.1790100109","article-title":"Costs and effectiveness of nonsteroidal anti-inflammatory drugs: the importance of reducing side effects","volume":"10","author":"Gabriel","year":"1997","journal-title":"Arthritis Care Res"},{"key":"10.1016\/S0049-0172(00)80017-7_bib40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF01451009","article-title":"Usage of complementary therapies in rheumatology: a systematic review","volume":"17","author":"Ernst","year":"1998","journal-title":"Clin Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib41","first-page":"2108","article-title":"The longterm outcomes of rheumatoid arthtitis: work disability a prospective 18 year study of 823 patients","volume":"25","author":"Wolfe","year":"1998","journal-title":"J Rheumatol"},{"issue":"Suppl 22","key":"10.1016\/S0049-0172(00)80017-7_bib42","first-page":"24","article-title":"50 years of antirheumatic therapy: the prognosis of rheumatoid arthritis","volume":"17","author":"Wolfe","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib43","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/art.1780270805","article-title":"Severe functional declines, work disability, and increased mortality in 75 rheumatoid arthritis patients studied for 9 years","volume":"27","author":"Pincus","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib44","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/art.1780310306","article-title":"The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis","volume":"31","author":"Mitchell","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0895-4356(89)90135-2","article-title":"Substantial work disability and earnings losses in individuals less than age 65 with osteoarthritis: comparisons with rheumatoid arthritis","volume":"42","author":"Pincus","year":"1989","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib46","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/rheumatology\/35.7.652","article-title":"Prediction of permanent work disability in a follow-up study of early rheumatoid arthritis: results of a tree structured analysis using RECPAM","volume":"35","author":"Mau","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib47","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/art.1780300504","article-title":"The work dynamics of the persons with rheumatoid arthritis","volume":"30","author":"Yelin","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02275601","article-title":"Prognosis of functional capacity and work capacity in rheumatoid arthritis","volume":"1","author":"Makisara","year":"1982","journal-title":"Clin Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib49","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/03009748709165410","article-title":"Work capacity of patients with inflammatory joint disease","volume":"16","author":"Kaarela","year":"1987","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0895-4356(92)90005-8","article-title":"Identification of work disability in rheumatoid arthritis: physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables","volume":"45","author":"Callahan","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib51","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0049-0172(91)90046-3","article-title":"Worldwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis","volume":"21","author":"Markenson","year":"1991","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib52","first-page":"3","article-title":"Cost of illness and the burden of disease","volume":"24","author":"Maetzel","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib53","first-page":"1480","article-title":"The clinical value of the Stanford health assessment questionnaire functional disability index in patients with rheumatoid arthritis","volume":"15","author":"Wolfe","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib54","first-page":"293","article-title":"Therapeutics: the management of rheumatoid arthritis of recent onset","volume":"105","author":"Palmer","year":"1992","journal-title":"N Z Med J"},{"key":"10.1016\/S0049-0172(00)80017-7_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199500501-00003","article-title":"The underestimated long term medical and economic consequences of rheumatoid arthritis","volume":"50","author":"Pincus","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/S0049-0172(00)80017-7_bib56","series-title":"presented at the ACR meeting","article-title":"Long-term medical costs and outcomes are significantly associated with early changes in disability in rheumatoid arthritis","author":"Singh","year":"1996"},{"key":"10.1016\/S0049-0172(00)80017-7_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/PL00007323","article-title":"Arbeitsunfaehigkeit im ersten Jahr den chronischen polyarthritis: ein vergleich mit pflichtmitgliedem den gesetzlichen krankenversicherung","volume":"56","author":"Mau","year":"1997","journal-title":"Z Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib58","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/art.1780240315","article-title":"The impact of chronic disease","volume":"24","author":"Meenan","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib59","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/art.1780340607","article-title":"The impact of rheumatoid arthritis on the household work performance of women","volume":"34","author":"Allaire","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0049-0172(00)80017-7_bib60","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2307\/3350132","article-title":"Expanding the definition of disability: implications for planning, policy, and research","volume":"70","author":"Reisine","year":"1992","journal-title":"Millbank Q"},{"key":"10.1016\/S0049-0172(00)80017-7_bib61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2106\/00004623-199303000-00002","article-title":"The hospital cost of total hip arthroplasty (a comparison between 1981 and 1990)","volume":"75","author":"Barber","year":"1993","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/S0049-0172(00)80017-7_bib62","first-page":"589","article-title":"Total knee arthroplasty: a population-based study","volume":"66","author":"Quam","year":"1991"},{"key":"10.1016\/S0049-0172(00)80017-7_bib63","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/07853890.1993.12088578","article-title":"Prosthetic osteomyelitis with special reference to the knee: risks, treatment and costs","volume":"25","author":"Bengtson","year":"1993","journal-title":"Ann Med"},{"key":"10.1016\/S0049-0172(00)80017-7_bib64","first-page":"295","article-title":"Maximising cost-effectiveness while minimising complications in total hip replacement","volume":"27","author":"Meding","year":"1998","journal-title":"Am J Orthop"},{"key":"10.1016\/S0049-0172(00)80017-7_bib65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00003086-199801000-00021","article-title":"Life expectancy and cost utility after total hip replacement","volume":"346","author":"Garellick","year":"1998","journal-title":"Clin Orthop"},{"key":"10.1016\/S0049-0172(00)80017-7_bib66","first-page":"21","article-title":"The economic cost of illness revisited","volume":"39","author":"Cooper","year":"1976","journal-title":"Soc Secur Bull"},{"key":"10.1016\/S0049-0172(00)80017-7_bib67","first-page":"867","article-title":"The economic impact of the rheumatic diseases in the United States","volume":"16","author":"Felts","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/S0049-0172(00)80017-7_bib68","first-page":"201","article-title":"Looking into the crystal ball: can we estimate the lifetime cost of rheumatoid arthritis?","volume":"12","author":"Bombardier","year":"1985","journal-title":"J Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017200800177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017200800177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T21:58:58Z","timestamp":1586037538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017200800177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["S0049017200800177"],"URL":"https:\/\/doi.org\/10.1016\/s0049-0172(00)80017-7","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}